Regeneron's RGC Signs a Research Collaboration with Colorado Center to Advance the Drug Discovery for Personalized Medicine
Shots:
- RGC and CCPM to create genomics database of 450-000 DNA samples and corresponding health record from de- identified patients who participated in UCHealth system- and will sequence the DNA samples while producing genomic data which will facilitate translational medical research enabling treatment option for patients
- The focus of the collbaortaion is to pair the sequence data with de-identified health records for aid in genomic medicine- drug discovery and personalized medicine approaches also leading to expansion of RCG's genomics initiatives
- Additionally- the CCPM physicians will also validate any genetic findings from the RGC data enabling the return of clinically-actionable results in their CLIA-certified lab
Click here to read full press release/ article | Ref: Regeneron | Image: Behance
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com